Obesity-induced immune dysfunction and immunosuppression: TEM observation of visceral and subcutaneous lymph node microarchitecture and immune cell interactions

References

[1] Foster MT, Pagliassotti MJ. Metabolic alterations following visceral fat removal and expansion: beyond anatomic location. Adipocyte. 2012;1:192–9.10.4161/adip.21756Search in Google Scholar PubMed

[2] Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief 2017;288:1–8.Search in Google Scholar

[3] Frasca D, Blomberg BB, Paganelli R. Aging, obesity, and inflammatory age-related diseases. Front Immunol. 2017;8:1745.10.3389/fimmu.2017.01745Search in Google Scholar PubMed

[4] Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–49.10.1161/ATVBAHA.107.159228Search in Google Scholar PubMed

[5] Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010. DOI: 10.1155/2010/289645.Search in Google Scholar

[6] Mauland KK, Eng O, Ytre-Hauge S, Tangen IL, Berg A, Salvesen HB, et al. High visceral fat percentage is associated with poor outcome in endometrial cancer. Oncotarget. 2017;8:105184–95.10.18632/oncotarget.21917Search in Google Scholar PubMed

[7] Hill JH, Solt C, Foster MT. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Horm Mol Biol Clin Invest. 2018;33(2). DOI: 10.1515/hmbci-2018-0012.Search in Google Scholar

[8] Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing. 2005;2:8.10.1186/1742-4933-2-8Search in Google Scholar PubMed

[9] Willard-Mack CL. Normal structure, function, and histology of lymph nodes. Toxicol Pathol. 2006;34:409–24.10.1080/01926230600867727Search in Google Scholar PubMed

[10] Pond CM, Mattacks CA. Interactions between adipose tissue around lymph nodes and lymphoid cells in vitro. J Lipid Res. 1995;36:2219–31.10.1016/S0022-2275(20)39206-3Search in Google Scholar PubMed

[11] Magnuson AM, Regan DP, Fouts JK, Booth AD, Dow SW, Foster MT. Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations. Cell Prolif. 2017;50. DOI: 10.1111/cpr.12365.Search in Google Scholar PubMed PubMed Central

[12] Caer C, Rouault C, Le Roy T, Poitou C, Aron-Wisnewsky J, Torcivia A, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep. 2017;7:3000.10.1038/s41598-017-02660-wSearch in Google Scholar PubMed PubMed Central

[13] Arngrim N, Simonsen L, Holst JJ, Bulow J. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? Int J Obes (Lond). 2013;37:748–50.10.1038/ijo.2012.98Search in Google Scholar PubMed

[14] Weitman ES, Aschen SZ, Farias-Eisner G, Albano N, Cuzzone DA, Ghanta S, et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One. 2013;8:e70703.10.1371/journal.pone.0070703Search in Google Scholar PubMed PubMed Central

[15] Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One. 2010;5:e9694.10.1371/journal.pone.0009694Search in Google Scholar PubMed PubMed Central

[16] Diaz E, Rodriguez A, Martin-Loeches I, Lorente L, del Mar Martin M, Pozo JC, et al. Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest. 2011;139:382–6.10.1378/chest.10-1160Search in Google Scholar PubMed

[17] Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis. 2011;53:413–21.10.1093/cid/cir442Search in Google Scholar PubMed PubMed Central

[18] Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood). 2010;235:1412–24.10.1258/ebm.2010.010227Search in Google Scholar PubMed

[19] Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13:981–1000.10.1016/j.autrev.2014.07.001Search in Google Scholar PubMed

[20] Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst. 2013;105:1344–54.10.1093/jnci/djt223Search in Google Scholar PubMed PubMed Central

[21] Novosad S, Khan S, Wolfe B, Khan A. Role of obesity in asthma control, the obesity-asthma phenotype. J Allergy. 2013;2013:538642.10.1155/2013/538642Search in Google Scholar PubMed PubMed Central

[22] Moore LL, Chadid S, Singer MR, Kreger BE, Denis GV. Metabolic health reduces risk of obesity-related cancer in framingham study adults. Cancer Epidemiol Biomarkers Prev. 2014;23:2057–65.10.1158/1055-9965.EPI-14-0240Search in Google Scholar PubMed PubMed Central

[23] Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71:298–306.10.1017/S0029665112000158Search in Google Scholar PubMed PubMed Central

[24] Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond). 2012;36:1072–7.10.1038/ijo.2011.208Search in Google Scholar PubMed PubMed Central

[25] Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. J Am Med Assoc. 1985;254:3187–9.10.1001/jama.1985.03360220053027Search in Google Scholar

[26] Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39:137–41.10.1080/08916930600597326Search in Google Scholar PubMed PubMed Central

[27] Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33:4422–9.10.1016/j.vaccine.2015.06.101Search in Google Scholar PubMed PubMed Central

[28] Costanzo AE, Taylor KR, Dutt S, Han PP, Fujioka K, Jameson JM. Obesity impairs gammadelta T cell homeostasis and antiviral function in humans. PLoS One. 2015;10:e0120918.10.1371/journal.pone.0120918Search in Google Scholar PubMed PubMed Central

[29] Mancuso P. Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther. 2013;26:412–9.10.1016/j.pupt.2012.04.006Search in Google Scholar PubMed PubMed Central

[30] Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kawada T, et al. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring). 2008;16:1261–9.10.1038/oby.2008.55Search in Google Scholar PubMed

[31] Kuprys PV, Tsukamoto H, Gao B, Jia L, McGowan J, Coopersmith CM J, et al. Summary of the 2018 alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol. 2018;77:11–18.10.1016/j.alcohol.2018.08.010Search in Google Scholar PubMed PubMed Central

[32] Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med. 2004;200:783–95.10.1084/jem.20040254Search in Google Scholar PubMed PubMed Central

[33] Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 2012;12:762–73.10.1038/nri3298Search in Google Scholar PubMed

[34] Cassimeris L, Zigmond SH. Chemoattractant stimulation of polymorphonuclear leucocyte locomotion. Semin Cell Biol. 1990;1:125–34.Search in Google Scholar PubMed

[35] Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity. 2005;22:19–29.10.1016/j.immuni.2004.11.013Search in Google Scholar PubMed

[36] den Brok MH, Raaijmakers TK, Collado-Camps E, Adema GJ. Lipid droplets as immune modulators in myeloid cells. Trends Immunol. 2018;39:380–92.10.1016/j.it.2018.01.012Search in Google Scholar PubMed

[37] Verdijk P, van Veelen PA, de Ru AH, Hensbergen PJ, Mizuno K, Koerten HK, et al. Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Eur J Immunol. 2004;34:156–64.10.1002/eji.200324241Search in Google Scholar PubMed

[38] Wilhelm M, King B, Silverman AJ, Silver R. Gonadal steroids regulate the number and activational state of mast cells in the medial habenula. Endocrinology. 2000;141:1178–86.10.1210/endo.141.3.7352Search in Google Scholar PubMed

[39] Textor J, Mandl JN, de Boer RJ. The reticular cell network: a robust backbone for immune responses. PLoS Biol. 2016;14:e2000827.10.1371/journal.pbio.2000827Search in Google Scholar PubMed PubMed Central

[40] Novkovic M, Onder L, Cupovic J, Abe J, Bomze D, Cremasco V, et al. Topological small-world organization of the fibroblastic reticular cell network determines lymph node functionality. PLoS Biol. 2016;14:e1002515.10.1371/journal.pbio.1002515Search in Google Scholar PubMed PubMed Central

[41] Brown FD, Turley SJ. Fibroblastic reticular cells: organization and regulation of the T lymphocyte life cycle. J Immunol. 2015;194:1389–94.10.4049/jimmunol.1402520Search in Google Scholar PubMed PubMed Central

[42] Valencia J, Jimenez E, Martinez VG, Del Amo BG, Hidalgo L, Entrena A, et al. Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools. Cytotherapy. 2017;19:640–53.10.1016/j.jcyt.2017.01.010Search in Google Scholar PubMed

[43] Yang CY, Vogt TK, Favre S, Scarpellino L, Huang HY, Tacchini-Cottier F, et al. Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes. Proc Natl Acad Sci USA. 2014;111:E109–18.10.1073/pnas.1312585111Search in Google Scholar

[44] Acton SE, Farrugia AJ, Astarita JL, Mourao-Sa D, Jenkins RP, Nye E, et al. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature. 2014;514:498–502.10.1038/nature13814Search in Google Scholar PubMed

[45] Buechler MB, Turley SJ. A short field guide to fibroblast function in immunity. Semin Immunol. 2018;35:48–58.10.1016/j.smim.2017.11.001Search in Google Scholar

[46] Cavalera M, Wang J, Frangogiannis NG. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res. 2014;164:323–35.10.1016/j.trsl.2014.05.001Search in Google Scholar PubMed

[47] Eschalier R, Rossignol P, Kearney-Schwartz A, Adamopoulos C, Karatzidou K, Fay R, et al. Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity. Hypertension (Dallas, TX: 1979). 2014;63:740–6.10.1161/HYPERTENSIONAHA.113.02419Search in Google Scholar

[48] Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118:1117–23.10.1016/S0016-5085(00)70364-7Search in Google Scholar PubMed

[49] Sharma K. Obesity, oxidative stress, and fibrosis in chronic kidney disease. Kidney Int Suppl. 2014;4:113–7.10.1038/kisup.2014.21Search in Google Scholar PubMed PubMed Central

[50] Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094.10.1172/JCI45887Search in Google Scholar PubMed PubMed Central

[51] Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, et al. Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009;29:4467–83.10.1128/MCB.00192-09Search in Google Scholar PubMed PubMed Central

[52] Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007;293:E1118–28.10.1152/ajpendo.00435.2007Search in Google Scholar PubMed

[53] Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007;56:901–11.10.2337/db06-0911Search in Google Scholar PubMed

[54] Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol. 1997;151:317–22.Search in Google Scholar PubMed

[55] Ravikanth M, Soujanya P, Manjunath K, Saraswathi TR, Ramachandran CR. Heterogenecity of fibroblasts. J Oral Maxillofac Pathol. 2011;15:247–50.10.4103/0973-029X.84516Search in Google Scholar PubMed

[56] Van Linthout S, Miteva K, Tschope C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res. 2014;102:258–69.10.1093/cvr/cvu062Search in Google Scholar PubMed

[57] Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973;137:1142–62.10.1084/jem.137.5.1142Search in Google Scholar PubMed

[58] Roozendaal R, Mebius RE, Kraal G. The conduit system of the lymph node. Int Immunol. 2008;20:1483–7.10.1093/intimm/dxn110Search in Google Scholar PubMed

[59] Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999;48:1332–5.10.1016/S0026-0495(99)90277-9Search in Google Scholar PubMed

[60] Fletcher AL, Acton SE, Knoblich K. Lymph node fibroblastic reticular cells in health and disease. Nat Rev Immunol. 2015;15:350–61.10.1038/nri3846Search in Google Scholar PubMed PubMed Central

[61] Anderson AO, Shaw S. Conduit for privileged communications in the lymph node. Immunity. 2005;22:3–5.10.1016/j.immuni.2005.01.003Search in Google Scholar PubMed

[62] Cremasco V, Woodruff MC, Onder L, Cupovic J, Nieves-Bonilla JM, Schildberg FA, et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol. 2014;15:973–81.10.1038/ni.2965Search in Google Scholar PubMed PubMed Central

[63] Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222:R113–27.10.1530/JOE-14-0283Search in Google Scholar PubMed

[64] Blüher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27:163–77.10.1016/j.beem.2013.02.005Search in Google Scholar PubMed

[65] Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity. 2013;21:E439–47.10.1002/oby.20135Search in Google Scholar PubMed PubMed Central

[66] Goossens GH. The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obesity Facts. 2017;10:207–15.10.1159/000471488Search in Google Scholar PubMed PubMed Central

[67] Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28:1304–10.10.1161/ATVBAHA.108.165100Search in Google Scholar PubMed

[68] Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–8.10.1111/j.1467-789X.2009.00623.xSearch in Google Scholar PubMed

[69] Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 2000;191:435–44.10.1084/jem.191.3.435Search in Google Scholar PubMed PubMed Central

[70] Worthington JJ, Czajkowska BI, Melton AC, Travis MA. Intestinal dendritic cells specialize to activate transforming growth factor-beta and induce Foxp3+ regulatory T cells via integrin alphavbeta8. Gastroenterology. 2011;141:1802–12.10.1053/j.gastro.2011.06.057Search in Google Scholar PubMed PubMed Central

[71] Sun JB, Czerkinsky C, Holmgren J. Sublingual ‘oral tolerance’ induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Scand J Immunol. 2007;66:278–86.10.1111/j.1365-3083.2007.01975.xSearch in Google Scholar PubMed

[72] Hadis U, Wahl B, Schulz O, Hardtke-Wolenski M, Schippers A, Wagner N, et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity. 2011;34:237–46.10.1016/j.immuni.2011.01.016Search in Google Scholar PubMed

[73] Worbs T, Bode U, Yan S, Hoffmann MW, Hintzen G, Bernhardt G, et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med. 2006;203:519–27.10.1084/jem.20052016Search in Google Scholar PubMed PubMed Central

[74] Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med. 2009;206:3101–14.10.1084/jem.20091925Search in Google Scholar PubMed PubMed Central

[75] Geem D, Ngo V, Harusato A, Chassaing B, Gewirtz AT, Newberry RD, et al. Contribution of mesenteric lymph nodes and GALT to the intestinal Foxp3+ regulatory T-cell compartment. Cell Mol Gastroenterol Hepatol. 2016;2:274–80.10.1016/j.jcmgh.2015.12.009Search in Google Scholar PubMed PubMed Central

[76] Harrell MI, Iritani BM, Ruddell A. Lymph node mapping in the mouse. J Immunol Methods. 2008;332:170–4.10.1016/j.jim.2007.11.012Search in Google Scholar PubMed PubMed Central